SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (53)9/30/2002 3:17:55 PM
From: Jibacoa  Read Replies (1) | Respond to of 3722
 
HEB Is up 27.50% with volume more than 4x its daily average after an analyst upgrade from "speculative buy" to "buy".<g> ( The "target" was also raised from $13.75 to $25. That would be a 2,400% gain from present levels.<G>)

"First year revenue after FDA approval for Ampligen's indications in HIV/AIDS and Chronic Fatigue Syndrome (CFS) are projected at $160 million. This is based on a market penetration of only 0.5%, which Mr. Garnet indicates maybe to conservative and consequently revenues could be significantly higher."

"The report expresses the belief that Ampligen has more than a 90% probability of obtaining FDA and European regulatory approval for both CFS and HIV/AIDS."

"Mr. Garnet has covered the Biotech Industry for over 10 years and has a strong track record for discovering undervalued small cap companies within the industry.".<g>

biz.yahoo.com

siliconinvestor.com

siliconinvestor.com

Bernard



To: Jibacoa who wrote (53)10/28/2002 12:00:35 PM
From: Jibacoa  Read Replies (1) | Respond to of 3722
 
SEPR Has continued its recent up-move that started on October 22. It traded for a while above the $9 level at 9.40AM and seems headed that way again in spite of the general market's turn to the down side.<g>

siliconinvestor.com

siliconinvestor.com

siliconinvestor.com

The industrials found some resistance this morning.<g>

siliconinvestor.com

But they still look good as long as they stay above the 8220 <g>

siliconinvestor.com

An the NAZ also ran into some resistance earlier.

siliconinvestor.com

But is stll holding its recent up-trend.<g>

siliconinvestor.com

Bernard